Litcius/Paper detail

Characterising lipoteichoic acid as an in vitro model of acute neuroinflammation

Anne-Marie Howe, Aoife Cosgrave, Maitiú Ó'Murchú, Conor Britchfield, Aoife Mulvagh, Iván Fernández-Pérez, Megan Dykstra, Aimée C. Jones, Derek A. Costello

2020International Immunopharmacology16 citationsDOIOpen Access PDF

Abstract

Toll-like receptor 2 (TLR2) is a primary sensor for pathogens, including those derived from gram-positive bacteria. It can also mediate the effects of endogenous inflammatory signals such as β-amyloid peptide (Aβ), thus promoting the microglial activation and subsequent neuronal dysfunction, characteristic of chronic neuroinflammatory conditions. More recently, a role for TLR2 has been proposed in the pathogenesis of disorders associated with acute inflammation, including anxiety and depression. The current study aims to characterise the acute effects of the TLR2 agonist lipoteichoic acid (LTA) on microglial activation and neuronal integrity, and to evaluate the influence of LTA exposure on sensitivity to the inflammation and neuronal dysfunction associated with Aβ. Using BV2 and N2a cells as an in vitro model, we highlight that acute exposure to LTA robustly promotes inflammatory cytokine and nitric oxide (NO) production in microglia but also in neurons, similar to that reported under longer-term and chronic inflammatory conditions. Moreover, we find that exposure to LTA can enhance sensitivity to subthreshold Aβ, promoting an 'M1'-like phenotype in microglia and provoking dysregulation of neuronal activity in acute hippocampal slices. Anti-inflammatory agents, including mimetics of brain-derived neurotrophic factor (BDNF), have proven effective at alleviating chronic neuroinflammatory complications. We further examined the effects of 7,8,3-trihydroxyflavone (7,8,3-THF), a small-molecule TrkB agonist, on LTA-induced microglial activation. We report that 7,8,3-THF can significantly ameliorate interleukin (IL)-6 and NO production in LTA-stimulated BV2 cells. Taken together, our findings offer support for exploration of TLR2 as a potential target for therapeutic intervention into acute neuroinflammatory conditions. Moreover we propose that exposure to gram-positive bacterial pathogens may promote sensitivity to the inflammatory changes characteristic of the aged brain.

Topics & Concepts

Lipoteichoic acidMicrogliaNeuroinflammationTLR2InflammationTLR4AgonistCytokineToll-like receptorReceptorMedicineImmunologyPharmacologyChemistryInnate immune systemBiologyImmune systemInternal medicineBacteriaGeneticsStaphylococcus aureusNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersImmune Response and Inflammation